The intestinal microbiota plays a central role for human physiology. Traditional studies have focused on the changes in microbiota composition under diverse conditions. Recently, efforts shifted towards understanding...
With the aim of obtaining a better overview of the occurrence of SARS-CoV-2 infections, a nationwide antibody study conducted by the Helmholtz Centre for Infection Research (HZI) was launched in the district of...
Jun Prof Jesko Köhnke heads the junior research group “Structural Biology of Biosynthetic Enzymes” at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection...
The Leibniz Institute for New Materials (INM), Saarland University (UdS) and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are launching the Leibniz Science Campus “Living Therapeutic Materials” on...
Prof Anna K. H. Hirsch recently received a prestigious European grant with a total funding volume of 3.2 million euros to initiate an Innovative Training Network (ITN) in the framework of the Marie Skłodowska-Curie...
Scientific data indicate that many COVID-19 cases are not recorded due to mild or asymptomatic infections. For this reason, there is at the time no sufficient data on how many people in Germany have already been...
Virologists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have identified a crucial survival factor in viruses. Their results were recently published in the scientific journal Proceedings of the...
In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria. Meningococci are bacteria that can...
